Salvation Nell

https://digitalcommons.library.umaine.edu/mmb-vp/4515/thumbnail.jp

Shared Decision Making and Decisional Conflict in Women with Postpartum Depression

Despite well documented adverse outcomes related to untreated postpartum depression, many women face difficulty accessing care. A woman’s experience of conflict related to appraising treatment options that align with both her needs and her values can contribute to delays or barriers to seeking and accessing effective treatment. Shared decision making is the cornerstone of a collaborative patient-provider relationship and has been shown to decrease patient’s experience of decisional conflict. This cross-sectional web-based survey examined the relationship between shared decision making and decisional conflict for postpartum women experiencing depressive symptoms at an urban counseling center in Nashville, TN. Data were collected between October and December 2019. Decisional conflict was measured using the Decisional Conflict Scale. Perception of shared decision making was measured using the Shared Decision-Making Questionnaire (SDMQ-9). A total of 169 women completed the online survey. Of the 121 women who reported symptoms of postpartum depression, less than half were currently engaged in care for PPD, Of the 48 women who were engaged in care, there was a significant negative correlation between shared decision making and decisional conflict, p\u3c.05, Pearson’s r = -.287. Results of this study confirm finding of existing research that many women who are experiencing symptoms of PPD are not engaging in care. However, when women engage in care that reflects the principles of shared decision-making, they experience less decisional conflict. Providers who practice shared decision making in their care of women with postpartum depression may improve treatment engagement as well as myriad health outcomes for women and children. Keywords: Postpartum Depression, Women, Decisional Conflict, Shared Decision Makin

Spinal Cord Injury and Osteoporosis: Causes, Mechanisms, and Rehabilitation Strategies

Spinal cord injury (SCI) has a huge impact on the individual, society and the economy. Though advances in acute care resulted in greatly reduced co-morbidities, there has been much less progress preventing long-term sequelae of SCI. Among the long-term consequences of SCI is bone loss (osteoporosis) due to the mechanical unloading of the paralyzed limbs and vascular dysfunction below the level of injury. Though osteoporosis may be partially prevented via pharmacologic interventions during the acute post-injury phase, there are no clinical guidelines to treat osteoporosis during the chronic phase. Thus there is need for scientific advances to improve the rehabilitative approaches to SCI-related osteoporosis. Recent advances in application of a new technology, functional electrical stimulation, provide a new and exciting opportunity to improve bone metabolism and to provide mechanical strain to the paralyzed lower limbs sufficient to stimulate new bone formation in individuals with SCI. The purpose of this minireview is to delineate our current understanding of SCI-related osteoporosis and to highlight recent literature towards its prevention and treatment

Study adherence in a tDCS longitudinal clinical trial with people with spinal cord injury

Study design Secondary analysis of a clinical trial.Objectives To analyze adherence to 1-year transcranial Direct Current Stimulation (tDCS) clinical trial in people with chronic pain due to spinal cord injury (SCI). We also explore the association between dropout and several baseline variables such as age, depression levels, pain severity, number of days with pain in the last 7 days, walking ability, sleep, work, relationship with others, and enjoyment with life.Setting Boston, USA.Methods Forty-six participants were enrolled in this trial, and 33 participants were randomized to receive either active or sham tDCS.Results Using the full intention-to-treat (ITT) criteria, only 8 participants (24%) finished the study. The median time to dropout was seven (IQR:6,19) sessions (i.e., immediately after the first follow-up), regardless of the type of stimulation that participants received (active vs. sham tDCS) (chi(2) = 0.025, p = 0.875). An exploratory analysis suggested that only the number of days with pain in the last 7 days was moderately associated with dropout, with people experiencing less pain being more prone to dropout from the study.Conclusions Despite all the measures to improve study adherence (such as providing parking, flexibility to schedule sessions, follow-up with participants by phone), it seems that long follow-up periods may increase the likelihood of dropout. Given the need to understand long-term effects of interventions, longitudinal trials need to consider alternative designs or methods of treatment (for instance home treatment or home assessment) to decrease attrition rate.This project was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers H133N110010 and 90SI5021-01-00). SC and JL are supported by the Portuguese Foundation for Science and Technology PTDC/MHC-PCN/3950/2014; SC is also funded by the following FCT grant IF/00091/2015

Feasibility of remotely-supervised tDCS in a person with neuropathic pain due to spinal cord injury

[Excerpt] Nearly 40% of people with spinal cord injury (SCI) report neuropathic pain that is often refractory to medications.1,2 Substantial research has shown that anodal transcranial direct current stimulation (tDCS) over the motor cortex can induce clinically significant pain relief in chronic pain.3–6 However, these clinical trials often require multiple study visits per trial and are associated to poor adherence to the study protocol. For instance, in our recent tDCS study in SCI, only 7 participants from the initial 46 that were enrolled completed the study.7 In fact, despite all attempts to improve adherence, such as flexibility to schedule sessions, free parking and follow-ups by the phone, most participants ended up dropping out from the study. Since many people with SCI have limited mobility, alternatives for home-based care are needed. Here we report the feasibility of supervised home-based tDCS application in a 57-year old woman with tetraplegia and sublesional neuropathic pain secondary to SCI since 2012. At time of enrollment, she self-reported pain as being 9 out of 10 in a visual analogue scale. [...]This project was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DP0035 and H133N110010)

Concurrent muscle and bone deterioration in a murine model of cancer cachexia

Cachexia is defined as an excessive, involuntary loss of fat and lean tissue. We tested the validity of the Lewis lung carcinoma (LLC) as a model of cancer cachexia and examined its effect on the two major lean tissue components, skeletal muscle and bone. LLC cells (0.75 × 106) were injected into the left thigh of C57BL/6 mice. Control mice received an equal volume injection of growth media. Tumors were observed in all LLC-injected animals 21 and 25 days post inoculation. LLC-injected animals showed significant reductions in fat and lean mass despite having the same average daily caloric intake as media-treated mice. Global bone mineral density (BMD) had fallen by 5% and 6% in the LLC animals at 21 and 25 days, respectively, compared to a BMD increase of 5% in the 25-day media-treated animals. Extensor digitorum longus (EDL) muscles (isolated from the noninjected hindlimb) showed earlier and quantitatively greater losses in mass, physiological cross-sectional area (pCSA), and tetanic force compared to soleus muscles from the same hindlimb. By the 25th day post-LLC inoculation, EDL force/pCSA was reduced by 19% versus media treatment. This loss in specific force was not trivial as it accounted for about one-third of the reduction in EDL absolute force at this time point. Muscle strips dissected from the diaphragm of LLC mice also exhibited significant reductions in force/pCSA at day 25. We conclude that LLC is a valid model of cachexia that induces rapid losses in global BMD and in limb and respiratory muscle function

Reliability and Validity of S3 Pressure Sensation as an Alternative to Deep Anal Pressure in Neurologic Classification of Persons With Spinal Cord Injury.

OBJECTIVE: To determine whether pressure sensation at the S3 dermatome (a new test) could be used in place of deep anal pressure (DAP) to determine completeness of injury as part of the International Standards for Neurological Classification of Spinal Cord Injury. DESIGN: Prospective, multicenter observational study. SETTING: U.S. Spinal Cord Injury Model Systems. PARTICIPANTS: Persons (N=125) with acute traumatic spinal cord injury (SCI), neurologic levels T12 and above, were serially examined at 1 month (baseline), 3, 6, and 12 months postinjury. There were 80 subjects with tetraplegia and 45 with paraplegia. INTERVENTIONS: S3 pressure sensation at all time points, with a retest at the 1-month time point. MAIN OUTCOME MEASURES: Test-retest reliability and agreement (κ), sensitivity, specificity, positive and negative predictive values. RESULTS: Test-retest reliability of S3 pressure at 1 month was almost perfect (κ=.98). Agreement of S3 pressure with DAP was substantial both at 1 month (κ=.73) and for all time points combined (κ=.76). The positive predictive value of S3 pressure for DAP was 89.3% at baseline and 90.3% for all time points. No pattern in outcomes was seen in those cases where S3 pressure and DAP differed at 1 month. CONCLUSIONS: S3 pressure sensation is reliable and has substantial agreement with DAP in persons with SCI at least 1 month postinjury. We suggest S3 pressure as an alternative test of sensory sacral sparing for supraconus SCI, at least in cases where DAP cannot be tested. Further research is needed to determine whether S3 pressure could replace DAP for classification of SCI